×
For best experience we recommend to activate Javascript in your browser.
CEBPA antibody
CEBPA
Reactivity: Human
FACS, IF
Host: Mouse
Monoclonal
16C12B70
unconjugated
Product Details anti-CEBPA Antibody
(hide)
Target
See all CEBPA Antibodies
CEBPA
(CCAAT/enhancer Binding Protein (C/EBP), alpha (CEBPA))
Reactivity
All reactivities for CEBPA antibodies
Human
Host
All hosts for CEBPA antibodies
Mouse
Clonality
All clonalities for CEBPA antibodies
Monoclonal
Conjugate
All conjugates for CEBPA antibodies
This CEBPA antibody is un-conjugated
Application
All applications for CEBPA antibodies
Flow Cytometry (FACS), Immunofluorescence (IF)
Cross-Reactivity
Mouse (Murine)
Cross-Reactivity (Details)
weakly cross-reacts with mouse
Purification
The antibody was purified by affinity chromatography.
Clone
16C12B70
Isotype
IgG2a kappa
Top Product
Discover our top product CEBPA Primary Antibody
Alternatives
(show)
anti-CCAAT/enhancer Binding Protein (C/EBP), alpha (CEBPA) (AA 288-337) antibody
CEBPA
Reactivity: Human, Mouse, Rat, Cow, Guinea Pig, Pig, Rabbit, Dog, Chicken
WB, IHC, IHC (p)
Host: Rabbit
Polyclonal
unconjugated
anti-CCAAT/enhancer Binding Protein (C/EBP), alpha (CEBPA) (Middle Region) antibody
CEBPA
Reactivity: Human, Mouse, Rat, Cow, Zebrafish (Danio rerio), Guinea Pig, Rabbit, Dog, Horse, Sheep
WB, IHC
Host: Rabbit
Polyclonal
unconjugated
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Concentration
0.5 mg/mL
Buffer
Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C
Storage Comment
The antibody solution should be stored undiluted between 2°C and 8°C.
Target Details for CEBPA
(hide)
Target
CEBPA
(CCAAT/enhancer Binding Protein (C/EBP), alpha (CEBPA))
Alternative Name
C/EBPalpha (CEBPA Products )
Synonyms
C/EBP-alpha antibody, CEBP antibody, C/ebpalpha antibody, CBF-A antibody, Cebp antibody, DBPCEP antibody, c/ebpa antibody, cb1062 antibody, wu:fj20f03 antibody, C/EBP antibody, C/EBPalpha antibody, xC/EBP antibody, cC/EBP antibody, C/EBP alpha antibody, CCAAT/enhancer binding protein alpha antibody, CCAAT/enhancer binding protein (C/EBP), alpha antibody, CCAAT/enhancer binding protein alpha L homeolog antibody, CEBPA antibody, Cebpa antibody, cebpa antibody, cebpa.L antibody
Background
The CCAAT-enhancer binding proteins (C/EBP) are members of the basic region/leucine zipper (bZIP) transcription factors, that bind to the consensus CCAAT sequence in DNA. C/EBPα is expressed in two isoforms: p42 and p30 by ultilizing different translational start codons. The C/EBPα p30 isoform has little to no transactivating activity and acts as an inhibitor. C/EBPα regulates expression of various myeloid-specific genes and is required for myeloid differentiation. C/EBPα has been found to play a key role in adipogenesis, since inhibition of C/EBPα blocks adipocyte differentiation. C/EBPα also regulates cell cycle progression through interactions with cyclin-dependent kinases (CDK) and by inducing the expression of CDK inhibitor p21. Mutations in the C/EBPα gene are associated with the development of acute myeloid leukemia.
Pathways
Brown Fat Cell Differentiation , Positive Regulation of fat Cell Differentiation
Recently viewed
(hide)